What We Learned

Background

Superbugs are bacteria, fungi, viruses, or parasites that cause disease and have developed antimicrobial resistance—meaning they no longer respond to at least some of the medicines used to treat them. However, the term “superbug” is most commonly used to refer to bacteria that have become antibiotic-resistant.

Globally, it is estimated that superbugs killed almost 1.3 million people and contributed to the death of nearly 5 million people in 2019 alone.

Where Do Superbugs Come From?

There are many kinds of bacteria, and the human body is home to an estimated 39 trillion bacteria—more than the number of cells—of all types. The vast majority is harmless and even provides important functions, but some can cause infections responsible for ailments from strep throat and whooping cough to Salmonella and tetanus.

Alexander Fleming discovered penicillin—the first antibiotic—in 1928. By 1945, Fleming had found penicillin-resistant bacteria and warned that people would die from antibiotic-resistant infections if antibiotics were not used wisely.

Bacteria reproduce quickly and are constantly mutating. Sometimes, they may stumble upon a mutation that provides a defense against threats, including drugs (see the process).

Every time bacteria are exposed to an antibiotic, there is a chance some bacteria will survive and develop resistance to the drug. This is more likely if patients do not take antibiotics as prescribed, including overuse. Examples of overuse or misuse include prescribing antibiotics for diseases unrelated to bacteria and the widespread use of antibiotics in agriculture for purposes other than treating disease.

Even isolated instances of antibiotic resistance can spread rapidly because bacteria have many different mechanisms for sharing genetic material with each other. So, if one bacterium has developed resistance to an antibiotic, it is able to pass that resistance to many other bacteria—even if they’re different types of bacteria.

Types of Superbugs

One notable example is MRSA (methicillin-resistant Staphylococcus aureus). S. aureus—the cause of staph infection—is a typically harmless bacteria found on the skin or nose that may cause serious health problems if it gets into cuts or wounds.

MRSA is strains that have developed resistance to antibiotic treatments, with often deadly consequences. It is responsible for more deaths than any other superbug, killing more than 120,000 people globally each year. Other superbugs are also lethal, such as Carbapenem-resistant Acinetobacter baumannii, or CRAB, which has a mortality rate of 47% (see top 10). Many superbugs are referred to as gram-negative, meaning they are enclosed in a protective outer membrane that makes it harder for the immune system to attack them (see overview).

Unfortunately, the superbug problem is getting worse. A 2024 study suggested that antimicrobial resistance could lead to a 70% increase in deaths attributable to superbugs by 2050, with older adults being most affected.

Fighting Superbugs

The research community continues to work on developing new antibiotics and other antimicrobial medicines. Many nations have signed on to a United Nations initiative to address the threat of superbugs through a variety of approaches, including the prevention of infections, a more targeted use of antibiotics, and efforts to address antibiotic use in agriculture.

There are also things you can do to reduce your risk of contracting a superbug: wash your hands, get vaccinated, use antibiotics according to the prescription, keep your pets healthy, and prepare food safely.

Dive Deeper

Relevant articles, podcasts, videos, and more from around the internet — curated and summarized by our team

graphic showing a superbug in a cape
Open link on pbs.org

Antibiotic resistance is a complex topic, but this episode of the PBS web series Be Smart offers an excellent introduction. While the episode dates to 2015, meaning some of the numbers are out of date, it provides a clear overview of the superbug crisis and what’s causing it—all in a video that is less than 10 minutes long.

Science VS podcast logo
Open link on gimletmedia.com

Superbugs are a very real problem, and that problem is getting worse. But researchers around the world are working to both advance our understanding of these pathogens and develop new medicines capable of helping patients. This podcast talks with several scientists on the frontier of superbug research, offering insight into what we know—and what the future of medicine may look like.

woman giving a TED talk
Open link on ted.com

We know that some superbugs exist, and that those superbugs are resistant to some or all medicines. But what does that really mean in practical terms? Maryn McKenna is a journalist who has been at the forefront of covering antibiotic resistance since 2007. In this TED talk, McKenna lays out the very real consequences of antibiotic resistance—and what needs to be done to address the problem.

image of bacteria
Open link on npr.org

The COVID-19 pandemic was caused by a virus, and viruses can’t be treated with antibiotics. But recent research finds that COVID patients were given a tremendous amount of antibiotics, contributing to the problem of antibiotic-resistant bacteria. Why? This NPR feature sheds light on an unexpected side effect of the pandemic, and what its consequences mean for the superbug crisis.

graphic of a spoon holding pills
Open link on wellcome.org

Scientists developed antibiotics to cure disease by killing bacteria. Now many bacteria have developed resistance to those antibiotics. So why don’t we just develop new antibiotics? In part, it’s a complex scientific challenge. But money also plays a significant role. This piece offers an excellent summary of the challenges facing the development of new antibiotics—which also apply to the development of other antimicrobial medicines.

scientist working in a lab
Open link on theguardian.com

A new class of antibiotics had not been discovered in more than 50 years—until late 2023, when MIT researchers announced a new antibiotic called Zosurabalpin. In animal testing, Zosurabalpin was able to treat at least one type of superbug. While the drug still needs to go through clinical trials, it is a significant advance at a time when new antibiotics are in great demand.

Explore all Superbugs

Search and uncover even more interesting information in our vast database of curated Superbugs resources